DK1383399T3 - Ernæringstilskud til behandling af maculadegeneration - Google Patents

Ernæringstilskud til behandling af maculadegeneration

Info

Publication number
DK1383399T3
DK1383399T3 DK02728516T DK02728516T DK1383399T3 DK 1383399 T3 DK1383399 T3 DK 1383399T3 DK 02728516 T DK02728516 T DK 02728516T DK 02728516 T DK02728516 T DK 02728516T DK 1383399 T3 DK1383399 T3 DK 1383399T3
Authority
DK
Denmark
Prior art keywords
treatment
macular degeneration
nutritional supplement
nutritional
supplement
Prior art date
Application number
DK02728516T
Other languages
Danish (da)
English (en)
Inventor
Cara Larraine Baustian
David A Souerwine
George Edwin Bunce
Leon Ellenbogen
Federick L Ferris Iii
Jin Kinoshita
James Cecil Smith Jr
Stephen Paul Bartels
Original Assignee
Bausch & Lomb
Us Gov Health & Human Serv
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25220168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1383399(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch & Lomb, Us Gov Health & Human Serv, Wyeth Corp filed Critical Bausch & Lomb
Application granted granted Critical
Publication of DK1383399T3 publication Critical patent/DK1383399T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
DK02728516T 2001-03-23 2002-03-19 Ernæringstilskud til behandling af maculadegeneration DK1383399T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/816,284 US6660297B2 (en) 2001-03-23 2001-03-23 Nutritional supplement to treat macular degeneration
PCT/US2002/008451 WO2002076242A1 (en) 2001-03-23 2002-03-19 Nutritional supplement to treat macular degeneration

Publications (1)

Publication Number Publication Date
DK1383399T3 true DK1383399T3 (da) 2005-01-24

Family

ID=25220168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02728516T DK1383399T3 (da) 2001-03-23 2002-03-19 Ernæringstilskud til behandling af maculadegeneration

Country Status (19)

Country Link
US (3) US6660297B2 (de)
EP (3) EP1516542B1 (de)
JP (2) JP3672554B2 (de)
KR (1) KR100539633B1 (de)
CN (1) CN1279844C (de)
AR (1) AR034220A1 (de)
AT (2) ATE429156T1 (de)
BR (2) BRPI0208640B1 (de)
CA (1) CA2449892C (de)
DE (2) DE60232104D1 (de)
DK (1) DK1383399T3 (de)
ES (2) ES2231692T3 (de)
HK (2) HK1061954A1 (de)
IL (2) IL158034A0 (de)
MX (1) MXPA03008606A (de)
PT (1) PT1383399E (de)
SG (1) SG126764A1 (de)
WO (1) WO2002076242A1 (de)
ZA (1) ZA200307241B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164035B2 (en) * 2000-01-07 2007-01-16 Newsome David A Zinc-monocysteine complex and method of using zinc-cysteine complexes
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
DE20300305U1 (de) 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Lutein
DE20300304U1 (de) * 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Zink
US20050112210A1 (en) * 2003-09-12 2005-05-26 Terry Grossman Eye nutritional supplement
WO2005065669A1 (en) * 2003-12-19 2005-07-21 Alcon, Inc. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
DE20320101U1 (de) * 2003-12-23 2004-04-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
US20050250745A1 (en) * 2004-02-25 2005-11-10 Seddon Johanna M Biomarkers for age-related macular degeneration (AMD)
US20050249820A1 (en) * 2004-05-04 2005-11-10 Akorn, Inc. Nutritional supplement for the treatment and prevention of macular degeneration
WO2005110375A1 (en) * 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
CA2587391A1 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
EP1865988A2 (de) * 2005-03-31 2007-12-19 AP Pharma, Inc. Peg-polyacetal-diblock- und -triblock-copolymere sowie pharmazeutische zusammensetzungen
JP2006333802A (ja) * 2005-06-03 2006-12-14 Pola Chem Ind Inc ニキビ用の食品組成物
US20070148106A1 (en) * 2005-06-15 2007-06-28 Karin Wertz Treatment, prevention, and modulation of aging of the skin
JP2009512626A (ja) * 2005-09-08 2009-03-26 ディーエスエム アイピー アセッツ ビー．ブイ． 加齢性黄斑変性症を処置又は予防する方法
JP5085329B2 (ja) * 2005-09-12 2012-11-28 協和発酵バイオ株式会社 α−リポ酸含有組成物
DE102005043379B4 (de) * 2005-09-16 2008-01-31 Uvex Arbeitsschutz Gmbh Arbeitsschutzbrillen
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US7951845B2 (en) * 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US20090155390A1 (en) * 2006-01-19 2009-06-18 Miller Josef M Composition and method of treating temporary and permanent hearing loss
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US7786100B2 (en) * 2006-03-20 2010-08-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
WO2007141764A1 (en) * 2006-06-08 2007-12-13 The Iams Company Use of at least one polyphenol for promoting eye health
US20110082218A1 (en) * 2006-06-15 2011-04-07 Karin Wertz Treatment and modulation of gene expression and skin aging
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20080095757A1 (en) * 2006-10-23 2008-04-24 Now Health Group, Inc. Vitamin c compositions
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
EP2187880B1 (de) 2007-09-12 2013-12-18 The Trustees of Columbia University in the City of New York Zusammensetzungen und verfahren zur behandlung von makuladegeneration
JP2010538674A (ja) 2007-09-19 2010-12-16 オフサルモファーマ・アクチェンゲゼルシャフト 栄養補助剤およびそのような補助剤を含む強化食品
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090226547A1 (en) * 2008-03-05 2009-09-10 Gilbard Jeffrey P Dietary Supplement For Eye Health
JP2011520788A (ja) 2008-04-18 2011-07-21 アリゾナ ボード オブ リージェンツ ア ボディー コープ．オブ ザ ステイト オブ アリゾナ アクティング フォー アンド オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ 加齢黄斑変性症を治療する方法および組成物ならびに加齢黄斑変性症を治療する化合物を識別する方法
WO2009129859A1 (en) 2008-04-24 2009-10-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Compositions and methods for maintaining, strengthening, improving, or promoting eye health
CN101595977B (zh) * 2008-06-02 2013-04-03 浙江医药股份有限公司新昌制药厂 有益于眼睛明视持久度的配方食品及其应用
JP2013509443A (ja) * 2009-11-01 2013-03-14 シンセティック バイオロジックス，インコーポレイテッド 胃保持性の経口用高用量亜鉛調製物
AU2011223190B2 (en) * 2010-03-05 2015-05-28 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
US9125940B2 (en) * 2011-02-03 2015-09-08 Zhuning Ma Compositions and methods for treating macular edema
US8652518B2 (en) * 2012-04-15 2014-02-18 Jahahreeh Finley Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
WO2014052880A1 (en) 2012-09-28 2014-04-03 Disilvestro Robert Nutritional supplements for eye health and related methods
US10274503B2 (en) 2013-05-08 2019-04-30 Vegenics Pty Limited Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
EP3273783A4 (de) 2015-03-26 2019-01-09 Omniactive Health Technologies Limited Verfahren zur verbesserung der visuellen funktion und darin verwendete zusammensetzungen
JP2016185939A (ja) * 2015-03-27 2016-10-27 ロート製薬株式会社 経口組成物
CN106174466A (zh) * 2015-05-26 2016-12-07 帝斯曼知识产权资产管理有限公司 一种口服营养组合物
CN106420816A (zh) * 2016-09-28 2017-02-22 北京瑞济善健康科技有限公司 缓解视疲劳和改善视觉功能的复方叶黄素固体制剂及其制备方法
CN109394838B (zh) * 2018-12-19 2021-05-07 安徽大学 一种治疗老年性黄斑变性的药物组合物
CN110075175A (zh) * 2019-05-16 2019-08-02 湖北思维特能生物科技有限公司 一种预防视网膜黄斑变性疾病的组合物
US20210322469A1 (en) * 2020-04-20 2021-10-21 Regents Of The University Of Minnesota Zinc and copper for the prophylaxis and treatment of covid-19

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156852A (en) * 1989-04-20 1992-10-20 La Haye Laboratories, Inc. Composition and method for combating macular degeneration
US5075116A (en) * 1989-04-20 1991-12-24 Lahaye Laboratories, Inc. Composition and method for treatment of macular degeneration
GB9219524D0 (en) 1992-09-15 1992-10-28 Smithkline Beecham Plc Novel composition
WO1996040092A1 (en) 1995-06-07 1996-12-19 The Howard Foundation Pharmaceutically active carotenoids
US5739156A (en) 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
JPH11511167A (ja) 1995-08-14 1999-09-28 オキシジェン インコーポレイティド カロテノイド−ニコチンアミド−亜鉛組成物およびこれを使用した治療方法
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
EP0930072A1 (de) 1998-01-13 1999-07-21 Kartar Dr. Lalvani Mineral- und Vitaminzubereitungen zur Behandlung des trockenen Auges
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6582721B1 (en) 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
WO2001091770A2 (en) 2000-06-01 2001-12-06 Theralife, Inc. Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
DE20012510U1 (de) 2000-07-17 2000-11-30 Klingmueller Martin Multivitamin- und Mineralstoffpräparat
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration

Also Published As

Publication number Publication date
EP1383399B1 (de) 2004-11-03
CN1535116A (zh) 2004-10-06
US8603522B2 (en) 2013-12-10
CN1279844C (zh) 2006-10-18
DE60232104D1 (de) 2009-06-04
WO2002076242A1 (en) 2002-10-03
EP1516542B1 (de) 2009-04-22
ES2324937T3 (es) 2009-08-20
CA2449892A1 (en) 2002-10-03
ATE429156T1 (de) 2009-05-15
PT1383399E (pt) 2005-02-28
IL158034A (en) 2006-04-10
ATE281085T1 (de) 2004-11-15
SG126764A1 (en) 2006-11-29
AR034220A1 (es) 2004-02-04
KR20040026648A (ko) 2004-03-31
DE60201824D1 (de) 2004-12-09
BRPI0208640B1 (pt) 2018-04-03
JP2004520436A (ja) 2004-07-08
CA2449892C (en) 2006-06-06
JP2004346058A (ja) 2004-12-09
EP1516542A1 (de) 2005-03-23
ES2231692T3 (es) 2005-05-16
EP1383399A1 (de) 2004-01-28
MXPA03008606A (es) 2005-07-25
IL158034A0 (en) 2004-03-28
DE60201824T2 (de) 2005-03-31
US6660297B2 (en) 2003-12-09
EP1447012A1 (de) 2004-08-18
US20020182266A1 (en) 2002-12-05
ZA200307241B (en) 2004-07-08
JP3672554B2 (ja) 2005-07-20
BR0208640A (pt) 2004-08-03
HK1061954A1 (en) 2004-10-15
KR100539633B1 (ko) 2005-12-29
US20040052863A1 (en) 2004-03-18
HK1076991A1 (en) 2006-02-03
US20050163864A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
DK1383399T3 (da) Ernæringstilskud til behandling af maculadegeneration
DE60236093D1 (de) Entfernbarer stent
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
EP1461028A4 (de) Behandlung für altersbezogene makuladegeneration
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
ATE314069T1 (de) Antineoplasische kombinationspräparate
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
FI20010694A0 (fi) Implantti
DE50105476D1 (de) Stent
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO20051281D0 (no) Sammensetning for anrikning av naeringsmidler
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
MA26341A1 (fr) Stents
ATE455748T1 (de) Vitamin-d-analoga
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
ATE333439T1 (de) Pflanzenkläranlage
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer
DE60311273D1 (de) Gemischtes schmuckset
FR2825911B1 (fr) Implant cotyloidien